Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Presentations
-
Durable Exon Skipping and Dystrophin Production With Endosomal Escape Vehicle (EEV™)–Oligonucleotide Conjugates in Preclinical Models of Duchenne Muscular Dystrophy
- By: Xiang Li, PhD, Director, Discovery Research, Entrada Therapeutics
- At: 20th Annual Meeting of the Oligonucleotide Therapeutics Society
- On: October 6, 2024
DownloadOctober 6, 2024 -
Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle
- By: Mark Shen, PhD, Sr. Scientist, Discovery Research, Entrada Therapeutics
- At: 20th Annual Meeting of the Oligonucleotide Therapeutics Society
- On: October 6, 2024
DownloadOctober 6, 2024 -
The Endosomal Escape Vehicle Platform Enhances Lipid Nanoparticle-Mediated Delivery of Genomic Medicines
- By: Mah Kheirabadi, PhD, Director, Discovery Chemistry, Entrada Therapeutics
- At: 3rd Annual Next Generation Lipid-Based Nanoparticles Delivery Summit
- On: August 22, 2024
DownloadAugust 22, 2024 -
Utility of a 3D–Engineered Skeletal Muscle Organoid System to Assess Exon Skipping, Dystrophin Protein Restoration, and Functional Improvement in a Human DMD Cell Model
- By: Nelsa Estrella, PhD, Associate Director, Neuromuscular, Entrada Therapeutics
- At: Society for Muscle Biology: Skeletal Muscle Stem Cells in Development Regenerations & Adaptations Conference
- On: July 14, 2024
DownloadJuly 14, 2024 -
Durable Exon Skipping and Dystrophin Production with Endosomal Escape Vehicle (EEV™) - Oligonucleotide Conjugates in Preclinical Models of DMD
- By: Xiang Li, PhD, Director, Discovery Research, Entrada Therapeutics
- At: 2024 RNA Therapeutics: From Concept to Clinic
- On: June 26, 2024
DownloadJune 26, 2024 -
Optimization and Application of the Endosomal Escape Vehicle (EEV™) Platform for Enhanced Delivery of Oligonucleotides to Skeletal and Cardiac Muscle
- By: Mark Shen, PhD, Sr. Scientist, Discovery Research, Entrada Therapeutics
- At: 2024 RNA Therapeutics: From Concept to Clinic
- On: June 26, 2024
DownloadJune 26, 2024